SMO and Hepatic fibrosis: Taken together, those results support our hypothesis that CP-MSCs release exosomes or MVs containing miRNA-125b into target cells, such as Hh-responsive HSCs, and hinder the activation of Hh signaling by inhibiting Smo expression, eventually alleviating hepatic fibrosis.